Search hospitals

>

Washington

>

Seattle

Harborview Medical Center

Claim this profile

Seattle, Washington 98104

Global Leader in Stroke

Global Leader in Lung Cancer

Conducts research for Breast Cancer

Conducts research for Lymphoma

Conducts research for Peroneal Nerve Injury

419 reported clinical trials

24 medical researchers

Photo of Harborview Medical Center in SeattlePhoto of Harborview Medical Center in Seattle

Summary

Harborview Medical Center is a medical facility located in Seattle, Washington. This center is recognized for care of Stroke, Lung Cancer, Breast Cancer, Lymphoma, Peroneal Nerve Injury and other specialties. Harborview Medical Center is involved with conducting 419 clinical trials across 591 conditions. There are 24 research doctors associated with this hospital, such as Charles Landis, MD, Charles Bernick, Michael Levitt, MD, and Lakshmi Rajdev.

Area of expertise

1

Stroke

Global Leader

Harborview Medical Center has run 25 trials for Stroke.

2

Lung Cancer

Global Leader

Harborview Medical Center has run 24 trials for Lung Cancer. Some of their research focus areas include:

Stage I
Stage II
Stage IV

Top PIs

Clinical Trials running at Harborview Medical Center

Stroke

Breast Cancer

Traumatic Brain Injury

Vascular Dementia

Bladder Cancer

Alzheimer's Disease

Sleep Apnea

Prostate Cancer

Hemorrhagic Shock

Bleeding

Image of trial facility.

Anti-Coagulant + Anti-Platelet Therapy

for Stroke Prevention

The primary goal of the trial is to determine if the experimental arms (rivaroxaban or ticagrelor or both) are superior to the clopidogrel arm for lowering the 1-year rate of ischemic stroke, intracerebral hemorrhage, or vascular death.

Recruiting

2 awards

Phase 3

6 criteria

Image of trial facility.

Semaglutide

for Type 2 Diabetes

A human subjects research study, the primary purpose of which is to assess the EFFECTS OF SEMAGLUTIDE ON INTRACRANIAL BLOOD FLOW AND BLOOD-BRAIN BARRIER PERMEABILITY IN TYPE-2 DIABETES (T2D) through testing of the intervention on patients in a clinical setting. The study will randomize subjects with diabetes to either semaglutide or matching placebo. Magnetic resonance images will be primary endpoint measured at baseline and at one year to assess effect of this FDA approved medication. Given the available evidence supporting the neuroprotective effect of this drug class and stroke reduction with semaglutide, and the investigators preliminary data showing that T2D had significantly reduced total number of distal arterial branches in the brain than non-T2D, the investigators expect treatment with semaglutide will be associated with improved intracranial blood flow condition.

Recruiting

2 awards

Phase 4

5 criteria

Image of trial facility.

Endovascular Thrombectomy

for Stroke

STEP is a Randomized, Multifactorial, Adaptive Platform trial that seeks to optimize the care of patients with acute ischemic stroke (AIS) due to large (LVO) or medium vessel occlusions (MVO).

Recruiting

1 award

N/A

2 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at Harborview Medical Center?

Where is Harborview Medical Center located?

Who should I call to ask about financial aid or insurance network?

What insurance does Harborview Medical Center accept?

What awards or recognition has Harborview Medical Center received?

Unbiased Results

We believe in providing patients with all the options.

Your Data Stays Your Data

We only share your information with the clinical trials you're trying to access.

Verified Trials Only

All of our trials are run by licensed doctors, researchers, and healthcare companies.

Terms of Service·Privacy Policy·Cookies·Security

Unbiased Results

We believe in providing patients with all the options.

Your Data Stays Your Data

We only share your information with the clinical trials you're trying to access.

Verified Trials Only

All of our trials are run by licensed doctors, researchers, and healthcare companies.

Terms of Service·Privacy Policy·Cookies·Security